Literature DB >> 10722235

Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction.

M C Cohen1, T H Aretz.   

Abstract

We sought to evaluate the underlying coronary pathology of fatal postoperative myocardial infarction (MI). It has been hypothesized that most MIs following noncardiac surgery occur in the setting of increased oxygen demand that exceeds coronary blood supply. However, most MIs not associated with surgery are caused by plaque rupture and intracoronary thrombosis. In a retrospective cohort study, we reviewed 1841 consecutive autopsy records from 1981 to 1995 at two institutions and identified 26 cases of postoperative MI with coronary arteries available. Plaque rupture was present in 12 cases (46%, 95% confidence interval [CI] 27%-67%). Of the 9 (35%) patients with intracoronary thrombus, 5 (56%; 19% of entire group) had total occlusion. Thrombus occurred on a >50% stenosis (by cross-sectional area) in a total of 33% (95% CI 16%-55%) of patients. The only statistically significant difference in clinical variables between patients with and without plaque rupture was longer interval from surgery to death in patients with plaque rupture (7.8+/-4.4 days versus 4.4+/-4.8 days; p = 0.047). In this autopsy series, coronary plaque rupture was associated with almost half of fatal postoperative MI cases. Strategies aimed at reducing triggers of plaque rupture with coronary occlusion might reduce postoperative MI fatality.

Entities:  

Mesh:

Year:  1999        PMID: 10722235     DOI: 10.1016/s1054-8807(98)00032-5

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  27 in total

Review 1.  [Perioperative beta-receptor blockade. For and against].

Authors:  B Preckel; M Poels; F Wappler; W Schlack; W Buhre
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

Review 2.  [Current aspects of anesthetic management in urological patients].

Authors:  O Groll; J Peters
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 3.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 4.  Managing patients undergoing non-cardiac surgery: need to shift emphasis from risk stratification to risk modification.

Authors:  G Karthikeyan; B Bhargava
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 5.  Preoperative cardiac testing before major vascular surgery.

Authors:  Sanne E Hoeks; Olaf Schouten; Maureen J van der Vlugt; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

Review 6.  Perioperative organ injury.

Authors:  Karsten Bartels; Jörn Karhausen; Eric T Clambey; Almut Grenz; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

Review 7.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

Review 8.  Perioperative clinical variables and long-term survival following vascular surgery.

Authors:  Santiago Garcia; Edward O McFalls
Journal:  World J Cardiol       Date:  2014-10-26

9.  High-Sensitivity Troponin in Noncardiac Surgery: Pandora's Box or Opportunity for Precision Perioperative Care?

Authors:  Aditya Mandawat; L Kristin Newby
Journal:  Circulation       Date:  2018-03-20       Impact factor: 29.690

10.  Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery.

Authors:  Willem-Jan Flu; Sanne E Hoeks; Jan-Peter van Kuijk; Jeroen J Bax; Don Poldermans
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.